Salta al contenuto principale
Toggle navigation
Live markets
Search
Search
Search
Search
My profile
My Subscriptions
Watchlists
Quote alerts
Create account
Sign in
IT
FR
EN
PT
NL
NB
DE
IT
Home
Company Press Releases
Company press releases
Registrati
Filtri
Filtri
Aggiorna
Ripristina
Icon After
Data
Toggle Visibility
Tutti
Oggi
Questa settimana
Questo mese
Custom date range
From
To
Topic
Toggle Visibility
Acquisition or disposal of the issuer’s own shares
Additional regulated information required to be disclosed under the laws of a Member State
Adjustment of interest rate
Alliances and agreements
Annual financial and audit Reports
Change in Capital
Changes in the rights attaching to the classes of shares or securities
Commercial operations
Commercial results
Corporate life
Dividend
Ex Date
General meeting / Board Meeting
Half yearly financial reports and audit reports/limited reviews
Home Member State
Income
Inside information
Joint venture
Journal / appointments
Legal
Major shareholding notifications
Mandatory notification of trade primary insiders
Meetings / events
Mergers, Acquiqitions, Transferts
New
New establishment
News contracts
Non-regulatory press releases
Other financial transaction
Other subject
Payments to governments
Polls / Surveys
Products and services
Prospectus / admission document
Rating
Sales
Share history
Share introduction and issues
Takeover bids
Total number of voting rights and capital
Trends / Analyses
Provider
Toggle Visibility
ActusNewsWire
BusinessWire
EQS Group
Euronext
GlobeNewswire
Les Echos
Marketwire
Modular Finance
Oslo Børs Newspoint
PR Newswire
Displaying 351 - 378 of 378 results
Released
Company
Title
Industry
Topic
02 Aug 2021
07:00 CEST
IPSEN
Ipsen and Exicure Enter Into Exclusive Collaboration Targeting Rare Neurodegenerative Disorders
20103015 Pharmaceuticals
Other subject
02 Aug 2021
07:00 CEST
IPSEN
Ipsen conclut un partenariat exclusif avec Exicure dans les maladies neurodégénératives rares
20103015 Pharmaceuticals
Other subject
29 Jul 2021
07:00 CEST
IPSEN
Ipsen publie de solides résultats pour le premier semestre 2021 et revoit à la hausse ses objectifs pour l’exercice en cours
20103015 Pharmaceuticals
Sales
29 Jul 2021
07:00 CEST
IPSEN
Ipsen Delivers Strong H1 2021 Results and Upgrades Full-Year Guidance
20103015 Pharmaceuticals
Sales
27 Jul 2021
19:02 CEST
IPSEN
Ipsen renforce son portefeuille en Oncologie en phase pré-clinique grâce à une collaboration mondiale exclusive avec BAKX Therapeutics Inc. pour le BKX-001, une molécule ciblant la voie de l’apoptose
20103015 Pharmaceuticals
Other subject
27 Jul 2021
19:01 CEST
IPSEN
Ipsen Strengthens Its Pre-clinical Oncology Pipeline With an Exclusive Worldwide-collaboration With BAKX Therapeutics Inc. for BKX-001, Targeting the Apoptosis Pathway
20103015 Pharmaceuticals
Other subject
27 Jul 2021
18:00 CEST
IPSEN
Ipsen : Déclaration des transactions sur actions propres réalisées du 19 au 23 Juillet 2021
20103015 Pharmaceuticals
Legal
27 Jul 2021
18:00 CEST
IPSEN
Ipsen: Disclosure Transaction in Own Shares Between 19/07/2021 And 23/07/2021
20103015 Pharmaceuticals
Legal
20 Jul 2021
18:00 CEST
IPSEN
Ipsen: Disclosure Transaction in Own Shares Between 12/07/2021 And 16/07/2021
20103015 Pharmaceuticals
Legal
20 Jul 2021
18:00 CEST
IPSEN
Ipsen : Déclaration des transactions sur actions propres réalisées du 12 au 16 Juillet 2021
20103015 Pharmaceuticals
Legal
15 Jul 2021
18:25 CEST
IPSEN
Ipsen et IRLAB concluent un accord de licence mondiale exclusif pour améliorer le quotidien de patients atteints de la maladie de Parkinson
20103015 Pharmaceuticals
Other subject
15 Jul 2021
18:25 CEST
IPSEN
Ipsen and IRLAB Enter Exclusive Worldwide Licensing Agreement Aimed to Improve the Lives of People Living with Parkinson’s Disease
20103015 Pharmaceuticals
Other subject
13 Jul 2021
18:00 CEST
IPSEN
Ipsen : Déclaration des transactions sur actions propres réalisées du 05 au 09 Juillet 2021
20103015 Pharmaceuticals
Legal
13 Jul 2021
18:00 CEST
IPSEN
Ipsen: Disclosure Transaction in Own Shares Between 05/07/2021 and 09/07/2021
20103015 Pharmaceuticals
Legal
09 Jul 2021
18:00 CEST
IPSEN
Bilan semestriel du contrat de liquidité entre IPSEN et NATIXIS ODDO BHF
20103015 Pharmaceuticals
Other subject
09 Jul 2021
18:00 CEST
IPSEN
Ipsen : Information mensuelle relative au nombre total des droits de vote et d’actions composant le capital social
20103015 Pharmaceuticals
Other subject
09 Jul 2021
18:00 CEST
IPSEN
Half-year Statement of IPSEN Liquidity Agreement With NATIXIS ODDO BHF
20103015 Pharmaceuticals
Other subject
09 Jul 2021
18:00 CEST
IPSEN
Ipsen: Monthly Information Relative to the Total Number of Voting Rights and Shares Composing the Share Capital
20103015 Pharmaceuticals
Other subject
06 Jul 2021
18:00 CEST
IPSEN
IPSEN: Disclosure Transaction in Own Shares Between 28/06/2021 and 02/07/2021
20103015 Pharmaceuticals
Legal
06 Jul 2021
18:00 CEST
IPSEN
IPSEN : Déclaration des transactions sur actions propres réalisées du 28 juin au 02 Juillet 2021
20103015 Pharmaceuticals
Legal
29 Jun 2021
18:00 CEST
IPSEN
Ipsen : Déclaration des transactions sur actions propres réalisées du 21 au 25 Juin 2021
20103015 Pharmaceuticals
Legal
29 Jun 2021
18:00 CEST
IPSEN
Ipsen: Disclosure Transaction in Own Shares Between 21/06/2021 and 25/06/2021
20103015 Pharmaceuticals
Legal
28 Jun 2021
07:00 CEST
IPSEN
Exelixis et Ipsen annoncent que le cabozantinib en association avec un inhibiteur de checkpoint immunitaire a considérablement amélioré la survie sans progression des patients atteints d’un cancer du foie avancé non traité au préalable
20103015 Pharmaceuticals
Other subject
28 Jun 2021
07:00 CEST
IPSEN
Exelixis and Ipsen Announce Cabozantinib in Combination with an Immune Checkpoint Inhibitor Significantly Improved Progression-Free Survival in Phase 3 COSMIC-312 Pivotal Trial in Patients with Previously Untreated Advanced Liver Cancer
20103015 Pharmaceuticals
Other subject
22 Jun 2021
18:00 CEST
IPSEN
Ipsen : Déclaration des transactions sur actions propres réalisées du 14 au 18 Juin 2021
20103015 Pharmaceuticals
Legal
22 Jun 2021
18:00 CEST
IPSEN
Ipsen: Disclosure Transaction in Own Shares Between 14/06/2021 and 18/06/2021
20103015 Pharmaceuticals
Legal
15 Jun 2021
18:00 CEST
IPSEN
Ipsen : Déclaration des transactions sur actions propres réalisées du 7 au 11 Juin 2021
20103015 Pharmaceuticals
Legal
15 Jun 2021
18:00 CEST
IPSEN
Ipsen: Disclosure Transaction in Own Shares between 07/06/2021 and 11/06/2021
20103015 Pharmaceuticals
Legal
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Paginazione
«
« First
‹
‹‹
6
7
8
Company press releases subscription
×
To subscribe to Press releases from this issuer, visit the Subscription to Company news section in
your account
section or
create an account
.
Home
Mercati
Amsterdam
Cash Products
Stocks
AEX index Stocks
AEX ESG Stocks
Indices
Funds
Bonds
ETFs
Structured products
Derivative products
Index options
Index futures
Stock options
Dividend derivatives
Stock futures
Quote Vendor Codes
Company regulated news
Latest
Archive
Brussels
Cash products
Stocks
Euronext regulated
Euronext Growth
Euronext Access
Expert Market
BEL 20 Stocks
Indices
Bonds
ETFs
Structured Products
Derivative products
Index futures
Stock options
Stock futures
Dividend derivatives
Quote Vendor Codes
Company regulated news
Latest
Archive
Expert Market
Dublin
Stocks
Euronext regulated
Euronext Growth
ISEQ 20 Stocks
Indices
Funds
Bonds
Irish Government Bonds
DOL
Lisbon
Cash Products
Stocks
Euronext regulated
Euronext Access
PSI Stocks
Indices
Bonds
Derivative products
Index futures
Stock futures
Dividend derivatives
Quote Vendor Codes
Company regulated news
Latest
Archive
Milan
Cash Products
Azioni
Euronext Milan
Euronext Growth Milan
Euronext Star Milan
Euronext Global Equity Market
EuroTLX
Trading After Hours
MIB ESG Azioni
Bonds
MOT
Euronext Access Milan
EuroTLX
Structured Products
SeDeX
EuroTLX
ETFs
Fondi
Derivative products
Tutti
Futures su indici
Opzioni su indici
Opzioni su azioni
Futures su azioni
Dividend futures
Quote Vendor Codes
IPOs
Oslo
Cash Products
Stocks
Oslo Børs
Euronext Growth
Euronext Expand
Top performers
OBX stocks
OBX ESG Stocks
OSEBX stocks
OSEFX Stocks
Seafood Stocks
Shipping Stocks
Equity indices
Bonds
Oslo Børs
Nordic Alternative Bond Market
Bond indices
ETFs
Funds
Derivatives
Derivative products
Quote Vendor Codes
Company regulated news
Latest
Archive
Financial calendars
Primary insiders
Paris
Cash Products
Stocks
Euronext regulated
Euronext Growth
Euronext Access
CAC 40 Stocks
CAC 40 ESG Stocks
Indices
Bonds
ETFs
Structured products
Derivative products
Index futures
Index options
Stock options
Stock futures
Dividend derivatives
Quote Vendor Codes
Company regulated news
Latest
Archive
Azioni
All Markets directories
All Markets
Euronext regulated
Euronext Growth
Euronext Access
Euronext Expand
Euronext Global Equity Market
EuroTLX
Trading After Hours
Company regulated news
Latest
Archive
IPOs
All IPOs
Listing sponsors
Euronext Tech Leaders
Family business
Indices
Directory
ESG indices
Indices documents
Indices news
Index consultations
Contact Euronext indices
ETFs
Directory
ESG ETFs
Funds
Directory
ESG Funds
Oslo Mutual Funds
Fixed Income
ESG Bonds
1.5° Bonds
All Markets directories
All Markets
Amsterdam
Brussels
Dublin
Lisbon
Oslo
Milan
Paris
Structured Products
Directory / search
Bid-Only trading status
Trading Turbos in the Netherlands
Equity Derivatives
Index Futures
Index Options
Stock Options
Stock Futures
Dividend Derivatives
ETF Options
Contracts specifications
Tick Sizes
Wholesale Trading
Quote vendor codes
Commodities
Quotes
Quotes snapshot
Milling Wheat futures
Rapeseed futures
Corn futures
European Durum Wheat Futures
Milling Wheat options
Rapeseed options
Corn options
Trading calendars
Delivery
Wholesale Trading
Commitments of Traders (CoT) report
Contracts specifications
Quote vendor codes
Knowledge Centre
Bid & Ask
Options Investing E-learning
Contract Specifications
Position Management
Intrinsic Value
Premium & Valuation
Moneyness
Positions
Euronext News
Resources
Statistics & reports
Quality of execution
Trading hours & Holidays
Contract specifications
Quote vendor codes
Key Information Document
Class level
Product group level
Notices / Corporate actions
Cash Notices / Corporate actions
Derivatives corporate actions
All Corporate Actions
Latest
Unusual Contract Sizes, Dividends
Corporate Action Services
Corporate Action Policies
Derivatives notices
Market events
Suspended instruments
Stressed Market Conditions
Breach of Double Cap limits
Exceptional Market Conditions
Miscellaneous short messages
Market status
Members list
Issuers compliance
Where to find